Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07210281) titled 'Osteogenon in Orthopedics and Traumatology' on Sept. 29.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: University of Opole

Condition: Patients With Fractures

Intervention: Drug: received an ossein-hydroxyapatite complex

Recruitment Status: Recruiting

Phase: Phase 4

Date of First Enrollment: November 1, 2024

Target Sample Size: 150

Countries of Recruitment: Poland

To know more, visit https://clinicaltrials.gov/study/NCT07210281

Published by HT Digital Content Service...